Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001941149 | SCV002217276 | uncertain significance | not provided | 2021-10-22 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 36 of the HNF4A protein (p.Ala36Thr). This variant is present in population databases (rs376906221, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with HNF4A-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001941149 | SCV004235301 | uncertain significance | not provided | 2023-06-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005023480 | SCV005656959 | uncertain significance | Maturity-onset diabetes of the young type 1; Type 2 diabetes mellitus; Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | 2024-02-26 | criteria provided, single submitter | clinical testing |